AI assistant
Sending…
Rallybio Corp — Director's Dealing 2026
Feb 24, 2026
34901_dirs_2026-02-23_adab4a67-2f0f-447f-8b8d-bb689687ef2b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Rallybio Corp (RLYB)
CIK: 0001739410
Period of Report: 2026-02-18
Reporting Person: Lieber Jonathan I (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-18 | Common Stock | A | 2500 | — | Acquired | 4904 | Direct |
| 2026-02-23 | Common Stock | S | 789 | $5.06 | Disposed | 4115 | Direct |
Footnotes
F1: The reporting person sold shares of common stock upon the partial vesting of a performance stock award, solely to satisfy tax withholding obligations incurred upon vesting.
More from Rallybio Corp
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 20
Major Shareholding Notification
2026
Feb 17
Regulatory Filings
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 2
Regulatory Filings
2025
Dec 23